-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_overview.pdf
March 27, 2014 - Disease-Modifying Antirheumatic Drugs … Document
Results of Topic Selection Process & Next Steps
§ The topic, Disease-Modifying Antirheumatic Drugs … Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis
(JIA). … update surveillance of Comparative Effectiveness Review (CER) #28: Disease-Modifying
Antirheumatic Drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
December 01, 2013 - San Diego (CA): Arena
Pharmaceuticals, Inc; 2010 Nov 9 [accessed 2011
Dec 16]. [3 p]. … New data from Arena Pharmaceuticals' pivotal
BLOSSOM trial of lorcaserin demonstrate
improvements … Washington (DC): Arena
Pharmaceuticals, Inc.; 2009 Oct 27 [accessed
2011 Apr 21]. [4 p]. … San
Diego (CA): Arena Pharmaceuticals; 2012 Jun 27
[accessed 2012 Jul 5]. [4 p]. … Arena Pharmaceuticals. Lorcaserin
hydrochloride. Drugs Future. 2007;32(9):766-70.
78.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-medication-use_research.pdf
April 01, 2014 - Care
for chronic physical and psychiatric conditions often includes the
use of multiple prescription drugs … Medicare
Part D program between 2005 and 2006, Medicare expenditures
for outpatient prescription drugs … Drugs are consolidated into 95
drug groups, and drug groups are
consolidated into 18 drug categories … Antipsychotic use: We considered
beneficiaries to be using antipsychotic or
antimanic drugs if they … Neuromuscular drugs Anticonvulsants
Cardiovascular agents Diuretics Neuromuscular drugs Antimyasthenic
-
effectivehealthcare.ahrq.gov/sites/default/files/kravitz_eccs2012.pdf
January 01, 2012 - Slide 6: Direct-‐to-‐Consumer Advertising
of Prescription Drugs … Products
Patients Remembered
Seeing Advertised
Percentage of
Patients Who
Requested
Advertised Drugs … condemnation cycle
Slide 11: Evaluating
the Accuracy and Balance of Media Reports
on
Prescription Drugs … Journalists
are
now in a difficult position with
regard
to
reporting on
prescription
drugs … • HealthNewsReview.org gives expert, independent review of media reports
on prescription drugs and
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-reporting-bias_methods.pdf
November 01, 2013 - Regulatory Documents
Reviews of Drugs Compared With Devices
Drugs and devices are both regulated by … • Reviewers should search Drugs@FDA for information on drugs; if a search is not
conducted reviewers … However, the Web site typically does not have
documents related to older drugs and very new drugs. … International Conference on Harmonisation of
Technical Requirements for Registration of
Pharmaceuticals … For
drugs: generic name, or temporary identifier for drugs that do not yet have a generic name;
for
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
May 19, 2010 - These drugs have been studied for
off-label use in several conditions. … published studies on
atypical antipsychotics and found that the most common off-label uses of the drugs … treatment for agitation in dementia, association between the increased risk of death
and antipsychotics drugs … Sub-Question 2: How do atypical antipsychotic medications compare with other
drugs, including first … How do they compare within the class and with other
drugs used for the conditions?
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1306.pdf
June 01, 2013 - Coordinating Council for Comparative Effectiveness
Research, AHRQ is interested in innovations in drugs … In the health care sector, horizon
scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … The topic,
buprenorphine implant (Probuphine,™ Titan Pharmaceuticals, Inc., South San Francisco, CA
-
effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_june_2012.pdf
January 01, 2012 - In the health care sector, horizon
scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … The search is on for ways to definitively diagnose AD and for drugs, biologics, and alternative
or … Peripheral and Central Nervous System Drugs
Advisory Committee.
-
effectivehealthcare.ahrq.gov/sites/default/files/14_substance_abuse_potential_high_impact_2012-12-11.pdf
January 01, 2012 - Coordinating Council for Comparative Effectiveness
Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … Results
The table below lists two topics for which (1) preliminary phase III data were available for
drugs … Prescription drugs: abuse and addiction. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_1.pdf
April 01, 2020 - Finally, although only a few prescription
drugs are approved by the U.S. … – There was minimal evidence addressing
whether efficacy of prescription drugs for
CATD treatment … (n=454),
and five that compared prescription drugs with
supplements (n=258). … Two trials compared different
prescription drugs (n=414). … Evidence on the efficacy and harms of CATD
drugs had several limitations.
-
effectivehealthcare.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
January 01, 2012 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Teduglutide (Gattex®, NPS Pharmaceuticals, Bedminster, NJ) is
a subcutaneously administered glucagon-like … Teduglutide (Gattex®, NPS Pharmaceuticals, Bedminster, NJ) is intended to provide several
critical … NPS Pharmaceuticals; 2011
May 12 [accessed 2011 Jul 15]. [2 p]. … Bedminster (NJ): NPS Pharmaceuticals,
Inc.; 2011 Oct 31 [accessed 2011 Nov 11]. [4 p].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
September 01, 2015 - health care sector,
horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For emerging pharmaceuticals or biotechnologies
23
that have not yet reached market and lack cost … information, we used as proxies novel
pharmaceuticals or biotechnologies entering the market within … Covers future industry
trends, key industry developments,
research and development of drugs and
pharmaceuticals … Industries covered:
pharmaceuticals, biotechnology,
medical equipment & devices, and in
vitro diagnostics
-
effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
September 01, 2015 - health care sector,
horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For emerging pharmaceuticals or biotechnologies
23
that have not yet reached market and lack cost … information, we used as proxies novel
pharmaceuticals or biotechnologies entering the market within … Covers future industry
trends, key industry developments,
research and development of drugs and
pharmaceuticals … Industries covered:
pharmaceuticals, biotechnology,
medical equipment & devices, and in
vitro diagnostics
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-evidence-summary-corticosteroids-asthma.pdf
October 01, 2017 - long-term maintenance treatment of asthma in patients
6 years and older.4
The review focuses on drugs … Drugs included in the review
Class Drugs
ICS Beclomethasone,a budesonide,a ciclesonide,a Flunisolide … Drugs 2009;69:137-150. PMID: 19228072.
4. Spiriva Respimat [package insert]. … Boehringer Ingelheim
Pharmaceuticals, Inc. Ridgefield, CT. 2016.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_executive.pdf
July 01, 2014 - benzodiazepines), and drugs for insomnia? … Interventions
Interventions include commonly used antidepressant drugs
listed in Table A. … • The drugs in Table A compared with each other
• Any nonpharmacological treatment. … searches (3,405 citations), manual
searches (53 citations), and scientific information packets
(Forest Pharmaceuticals … , Inc.; Jazz Pharmaceuticals;
and Sanofi Aventis, U.S.), we identified a total of 3,458
potentially
-
effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_2012-12-10.pdf
January 01, 2012 - In the health care sector, horizon
scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … The search is on for ways to definitively diagnose AD and for drugs, biologics, and alternative
or … Peripheral and Central Nervous System Drugs
Advisory Committee.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-cardiovascular-elderly_research.pdf
February 01, 2009 - .10 Another
observational study found higher mortality in those given haloperidol vs. two atypical drugs … FDA warns antipsychotic drugs
may be risky for elderly. JAMA
2005;293:2462.
3. Strong C. … Using antipsychotic agents in older
patients: expert consensus panel for using
antipsychotic drugs … Antipsychotic
drugs: prolonged QTc Interval, Torsade de
Pointes, and sudden death. … Antipsychotic
drugs in dementia: what should be made of
the risks? JAMA 2005;294:1963-1965.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_executive.pdf
April 01, 2012 - The
absolute risk difference in continence was less than
20 percent for all drugs. … Adverse effects were
common with all drugs and varied between the drugs. … Treatment
discontinuation due to adverse effects of drugs is
common. … Benefits and harms with drugs did not differ
by individual quality criteria. … • Drugs for urgency UI demonstrated similar
effectiveness.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/executive-summary-2017-schizophrenia-adult.pdf
January 01, 2017 - and in 2013 for SGA versus
SGA drugs. … in effects
associated with individual drugs. … This analysis found that all of the drugs
included were superior to placebo. … The newer drugs
primarily have evidence only for symptom-based outcomes
and adverse events. … • Ensure comparable dosing with the best dosing titration
methods for all drugs included.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
January 01, 2013 - CER #51:
Dietary Supplements in Adults Taking Cardiovascular
Drugs
Original release date:
April … ................................ 5
1
Dietary Supplements in Adults Taking Cardiovascular
Drugs … Comparative Effectiveness Review (CER) #51, Dietary Supplements in Adults Taking
Cardiovascular Drugs … Dietary
Supplements in Adults Taking
Cardiovascular Drugs. … OR exp Phytotherapy/ or
exp Plant Preparations/ or exp Plant Extracts/ or exp Drugs, Chinese Herbal/